NorthWest Biotherapeutics Inc (NWBO)

[Umibe5690]

I spoke with Les Goldman today. He made clear that NWBO has nothing to do with this clinical trial. UCLA is using a DC VAX variant. Les said that UCLA--LL and RP--are scientists. UCLA is very well funded for scientific research. Throughout the conduct of the DC VAX L trial, UCLA has conducted a number of these "independent" trials--and with NWBO blessing. LL knows DC VAX works but it is not a cure. It does not work equally well across all cancer types and so, as a scientist, she is looking for answers and improving what they have so far. This clinical trial is the latest in a series of trials UCLA has conducted over the years. There is no competition or distancing away from NWBO. This trial is business as usual following a similar pattern as in prior years. These variants are "tweaks" and so far, there has not been significant progress in developing a better mouse trap. No worries as Les has declared that.."we are many years ahead of them with a potentially commercialised product." FWIW.